Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Regulatory News

Date Source Headline
25th Apr 2019 7:00 am RNS Regulatory and Trading Update
18th Mar 2019 4:41 pm RNS Second Price Monitoring Extn
18th Mar 2019 4:36 pm RNS Price Monitoring Extension
18th Mar 2019 11:30 am EQS Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view
18th Mar 2019 11:05 am RNS Second Price Monitoring Extn
18th Mar 2019 11:00 am RNS Price Monitoring Extension
18th Mar 2019 9:05 am RNS Second Price Monitoring Extn
18th Mar 2019 9:00 am RNS Price Monitoring Extension
18th Mar 2019 7:00 am RNS Top Line Phase III results from B301 trial
6th Mar 2019 12:10 pm EQS Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share
6th Mar 2019 7:00 am RNS Interim Results
17th Jan 2019 9:56 am EQS Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
16th Jan 2019 7:00 am RNS Trading Update & Notice of Results
29th Nov 2018 5:59 pm RNS Holdings in Company
27th Nov 2018 1:12 pm RNS Result of AGM
27th Nov 2018 7:00 am RNS AGM Trading Update
12th Nov 2018 12:00 pm RNS Presentation at Jefferies Healthcare Conference
8th Nov 2018 7:00 am RNS Directorate Change
7th Nov 2018 6:06 pm RNS Holdings in Company
2nd Nov 2018 7:00 am RNS Grant of Awards under Long Term Incentive Plan
24th Oct 2018 1:25 pm RNS Holdings in Company
24th Oct 2018 7:00 am RNS Director/PDMR Shareholding
23rd Oct 2018 5:29 pm RNS Annual Report and Accounts
23rd Oct 2018 3:28 pm RNS Holdings in Company
27th Sep 2018 7:15 am EQS Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth
26th Sep 2018 7:00 am RNS Preliminary Results
8th Aug 2018 7:00 am RNS Notice of Results
27th Jul 2018 5:26 pm RNS Holding(s) in Company
26th Jul 2018 12:02 pm RNS Holding(s) in Company
19th Jul 2018 10:19 am RNS Results of Placing and Subscription
19th Jul 2018 7:00 am RNS Proposed placing & subscription to raise £10.6m
16th Jul 2018 8:53 am RNS BLOCK LISTING SIX MONTHLY RETURN
13th Jul 2018 9:40 am EQS Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
12th Jul 2018 7:00 am RNS Trading Update
25th Jun 2018 7:52 am RNS Positive data of Pollinex Quattro Grass vaccine
29th May 2018 7:00 am RNS Positive data with house-dust mite immunotherapy
21st May 2018 12:25 pm EQS Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration
21st May 2018 7:00 am RNS Positive top-line results from Grass Ph II study
14th May 2018 7:00 am RNS Publication of MCT Adjuvant Data
16th Mar 2018 3:38 pm RNS Grant of Awards under Long Term Incentive Plan
FTSE 100 Latest
Value10,559.58
Change-49.48